Responsive Nature-Driven Imagery to Reduce Delirium After Cardiac Surgery
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: A novel device developed providing nature-driven responsive imagery that responds to the patient's physiological to distract, engage, and de-escalate behaviours of delirium., Routine post-operative management and standard delirium reduction measures..
- Who it may be relevant to
- Registry conditions: Delirium - Postoperative, Agitation, Anxiety, Cardiac Surgery Recovery. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Canada
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Responsive Nature-Driven Imagery to Reduce Delirium After Cardiac Surgery: A Pilot Randomized Controlled Trial
Overview
The goal of this clinical trial is to learn if a novel device (MindfulGarden) is beneficial in a population of patients undergoing cardiac surgery. The main questions it aims to answer are: Is a novel device (MindfulGarden) that uses responsive nature-driven imagery feasible in patients undergoing cardiac surgery? Will use of this device reduce the use of psychotropic medications, improve recovery experience, and improve delirium? Participants will receive routine post-operative management and standard delirium reduction measures. They will be randomized into two groups where one receives the novel device (MindfulGarden) and the other does not.
Detailed description
Hypotheses:
This study will explore: (1) the feasibility of using Mindful Garden-a novel, nature-based digital therapeutic device offering responsive imagery and sound with biofeedback-in patients undergoing cardiac surgery; and (2) whether its use reduces psychotropic medication use, agitation, anxiety, and both the incidence and duration of postoperative delirium.
Rationale:
Delirium is a frequent, serious complication after cardiac surgery, leading to prolonged hospital stays, increased costs, and higher mortality rates. Although medications are often used to manage delirium-related behavior, they can lead to over-sedation and do not reliably prevent or treat delirium. There is an urgent need for safe, effective, non-pharmacological interventions in high-risk groups. Mindful Garden offers a screen-based display of dynamic nature scenes with interactive elements that respond to physiological cues. In prior ICU settings, brief exposure to Mindful Garden reduced agitation and the need for unscheduled medications. However, its effectiveness in preventing or managing delirium specifically in cardiac surgical patients remains unexplored.
Objectives:
The primary goals are to evaluate the feasibility of implementing Mindful Garden (in terms of recruitment, adherence, data completeness), its usage patterns, and patient satisfaction. Secondary aims include assessing the device's impact on delirium incidence and severity, need for psychotropic medications, agitation levels, anxiety, postoperative recovery, and length of hospital stay.
Participants:
This pilot randomized controlled trial will enroll 60 adult patients (aged ≥18 years) undergoing open-heart surgery at St. Paul's Hospital in Vancouver, Canada. Each arm will include 30 patients. Participants must have at least one risk factor for delirium, including being aged 64 or older, a history of delirium, stroke or TIA, cognitive impairment, or depression. Individuals with severe pre-existing cognitive impairments will be excluded.
Intervention:
Participants will be randomized 1:1 to either the Mindful Garden intervention or standard care. Due to the nature of the intervention, blinding is not feasible. In the intervention group, the Mindful Garden device will be made available for up to 7 days postoperatively or until discharge. All participants will receive standard post-operative care, including routine non-drug delirium prevention measures.
Outcomes:
Primary feasibility outcomes include recruitment success, adherence to study protocol, and participant satisfaction. Secondary clinical outcomes involve:
* Frequency of unscheduled psychotropic medication use * Incidence and severity of delirium (measured via the Intensive Care Delirium Screening Checklist and Confusion Assessment Method) * Agitation (Richmond Agitation Sedation Scale) * Anxiety (State Trait Anxiety Inventory) * Recovery quality (QoR-15 score) * Presence of Hallucinations (PSYRATS) * Hospital length of stay
Anticipated Impact:
This pilot trial will assess whether integrating the Mindful Garden device into post-cardiac surgery care is practical and beneficial. Results will inform a larger trial and may support broader implementation of non-pharmacological digital therapeutics to enhance recovery, reduce delirium, and minimize reliance on psychoactive drugs in surgical settings.
Interventions
- Device A novel device developed providing nature-driven responsive imagery that responds to the patient's physiological to distract, engage, and de-escalate behaviours of delirium.
This device will be provided on top of routine post-operative management and standard delirium reduction measures. It has proven effective in a previous clinical trial by reducing agitation and unscheduled medications. It displays nature-driven responsive imagery through an available mobile screen/device for the first 7 days after surgery or discharge, whichever comes first. The imagery adapts in real-time to the participant's movement and sound. The device will be placed at the foot of the bed - Procedure Routine post-operative management and standard delirium reduction measures.
Examples of routine post-operative care are sleep optimization, avoidance of delirium-promoting medications, orientation, and mobilization.
Primary outcome measures
- Recruitment Rate [Time frame: Day 0]
- Adherence to Protocol Rate [Time frame: Day 30 post surgery]
- Time Spent with Device [Time frame: Day 7 post surgery or discharge, whichever comes first]
- Patient Satisfaction and Perceived Benefits [Time frame: Day 7 post surgery or discharge, whichever comes first]
Secondary outcome measures (7)
- Incidence and Severity (days) of Delirium [Time frame: Twice daily until Day 7 post surgery or discharge, whichever comes first]
- Number of Unscheduled Psychoactive Medications or IV Infusions [Time frame: Day 7 post surgery or discharge, whichever comes first]
- Agitation in CSICU [Time frame: Every 4 hours while admitted to CSICU]
- Patient reported outcomes of anxiety [Time frame: Day 0, 3, 30 post surgery]
- Length of CSICU and hospital stays (days) [Time frame: Day 30 or day of discharge, whichever comes first]
- Patient reported Quality of Recovery [Time frame: Day 0, 3, 30 post surgery]
- Presence of hallucinations and delusions [Time frame: Day 3 post surgery]
Eligibility criteria
Inclusion criteria
- Planned open-heart cardiac surgery (e.g. coronary artery bypass grafting, valve replacement surgery);
- Able to understand study procedures and provide informed consent in English;
- At least one delirium risk factor: 1) Age less than 65yrs; 2) History of delirium; 3) History of stroke/TIA; 4) Known cognitive impairment; 5) Depression requiring medication.
Exclusion criteria
- Severe pre-existing cognitive impairment (Montreal Cognitive Assessment \[MOCA6\]<10)
- Uncorrected visual impairment;
- Significant impairment from psychiatric disease;
- Enrolment in another clinical trial which may interfere with the study outcome measures.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Prevention
Study locations
Canada · 1 center
- St. Paul's Hospital — Vancouver
Publications
- Nicholas M, Wittmann J, Norena M, Ornowska M, Reynolds S. A randomized, clinical trial investigating the use of a digital intervention to reduce delirium-associated agitation. NPJ Digit Med. 2023 Oct 30;6(1):202. doi: 10.1038/s41746-023-00950-4. PMID 37903857
- Tse L, Schwarz SK, Bowering JB, Moore RL, Barr AM. Incidence of and Risk Factors for Delirium After Cardiac Surgery at a Quaternary Care Center: A Retrospective Cohort Study. J Cardiothorac Vasc Anesth. 2015 Dec;29(6):1472-9. doi: 10.1053/j.jvca.2015.06.018. Epub 2015 Jun 12. PMID 26395395
Identifiers
NCT: NCT07051096 · H24-03693